Clinical Trial Update: Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating single-step antigen loading and Toll-like receptor activation of dendritic cells in melanoma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Radboud University Medical Center | Conditions: Melanoma | Phase 1, Phase 2 | Status: COMPLETED